Antidepressants for smoking cessation - ORA - Oxford University Research Archive

Abstract:: Background:
Whilst the pharmacological profiles and mechanisms of antidepressants are varied, there are common reasons why they might help people to stop smoking tobacco. Firstly, nicotine withdrawal may produce depressive symptoms and antidepressants may relieve these. Additionally, some antidepressants may have a specific effect on neural pathways or receptors that underlie nicotine addiction.

Objectives:
To assess the evide...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020). Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, 4, CD000031.

MLA Style

Howes, S, et al. “Antidepressants for Smoking Cessation.” Cochrane Database of Systematic Reviews, no. 4, 2020, p. CD000031.

Chicago Style

Howes, S, J Hartmann-Boyce, J Livingstone-Banks, B Hong, and N Lindson. 2020. “Antidepressants for Smoking Cessation.” Cochrane Database of Systematic Reviews, no. 4: CD000031.
Print

Access Document

Files:: Howes_et_al_Antidepressants_for_smoking_cessation.pdf

(Preview, Version of record, pdf, 2.1MB, Terms of use)

Publisher copy:: 10.1002/14651858.cd000031.pub5

Authors

+ Howes, S More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Primary Care Health Sciences
Role:: Author

+ Hartmann-Boyce, J More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Primary Care Health Sciences
Role:: Author

+ Livingstone-Banks, J More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Primary Care Health Sciences
Role:: Author
ORCID:: 0000-0002-3757-5591

+ Hong, B More by this author

Role:: Author
ORCID:: 0000-0002-0866-2012

+ Lindson, N More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Primary Care Health Sciences
Role:: Author
ORCID:: 0000-0003-2539-9268

Publisher:: Cochrane Collaboration
Journal:: Cochrane Database of Systematic Reviews More from this journal
Issue:: 4
Pages:: CD000031
Place of publication:: England
Publication date:: 2020-04-22
DOI:: 10.1002/14651858.cd000031.pub5
EISSN:: 1469-493X
ISSN:: 1469-493X
Pmid:: 32319681

Language:: English
Keywords:: FFR

smoking cessation

randomized controlled trials

nortriptyline

bupropion

anti-anxiety agents

antidepressive agents

serotonin uptake inhibitors

tobacco use cessation devices

smoking
Subtype:: Review
Pubs id:: 1101289
Local pid:: pubs:1101289
Deposit date:: 2020-06-01
ARK identifier:: ark:/29072/ora_09c4a522be7f4673804849a9c37eee0d

Terms of use

Copyright holder:: Cochrane Collaboration
Copyright date:: 2020
Rights statement:: Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Notes:: This is the publisher's version of the article. The final version is available online from the Cochrane Collaboration at: https://doi.org/10.1002/14651858.CD000031.pub5

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP